eGFR slope as predictor of mortality in heart failure patients

Sofie Verstreken,Monika Beles,Clara L. Oeste,Ana Moya,Imke Masuy,Riet Dierckx,Ward Heggermont,Jeroen Dauw,Dries Hens,Jozef Bartunek,Marc Vanderheyden
DOI: https://doi.org/10.1002/ehf2.15128
2024-11-29
ESC Heart Failure
Abstract:Aims Heart failure (HF) leads to an imbalance between heart and kidney function, resulting in poor outcomes. However, the prognostic significance of the estimated glomerular filtration rate (eGFR) trajectory in HF patients remains unclear. We analysed electronic health records (EHRs) of real‐world HF patients, assessing eGFR trajectories and their impact on mortality. Methods and results Retrospective clinical data of HF patients were processed using natural language processing. Chronic kidney disease (CKD) was evaluated, and eGFR trajectories were analysed using linear mixed‐effects models. Cox proportional hazard models were used to evaluate the relationship between baseline variables and mortality, while joint modelling combined eGFR trends and mortality. The dataset comprised 1986 patients, with a mean age of 74.8 years (SD ± 11.7) and 58% male. At the time of HF diagnosis, 58% of patients were diagnosed with CKD, and 39% presented with heart failure with preserved ejection fraction (HFpEF). The median follow‐up duration was 3.16 years, during which 399 patients (20%) died. Patients with CKD were significantly older and exhibited a higher prevalence of myocardial infarction (P = 0.048), coronary revascularization (P = 0.004), stroke (P
cardiac & cardiovascular systems
What problem does this paper attempt to address?